Form D Explorer

Form D — Volastra Therapeutics, Inc.

0001968822-25-000002 · filed Sep 23, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$30,099,998
Reported amount sold
$30,099,998
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Volastra Therapeutics, Inc.
CIK
1968822
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
1361 AMSTERDAM AVENUE
NEW YORK, NY 10027
Phone
646-344-1248

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗